ASCOLT: ASpirin for Dukes C and high risk B COLorecTal cancer. An International, Multi-centre, Double Blind, Randomised Trial

  • Segelov, Eva (Primary Chief Investigator (PCI))
  • Simes, R John (Chief Investigator (CI))
  • Jeffery, Mark (Chief Investigator (CI))
  • Chia, John Whay Kuang (Chief Investigator (CI))
  • Tebbutt, Niall C. (Chief Investigator (CI))
  • Chantrill, Lorraine A. (Chief Investigator (CI))
  • Frentzas, Sophia (Chief Investigator (CI))
  • Zielinski, Robert R. (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date21/12/20 → 20/12/22

Keywords

  • Aspirin
  • Colorectal Cancer
  • Randomised trial